Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 18
Selected: 0
NCT IDTitle
NCT05089266Study of αPD1-MSLN-CAR T Cells to Evaluate the Safety, Tolerability, and Effectiveness for Patients With MSLN-positive Advanced Solid Tumors
NCT04489862αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors
NCT04250324Study of Safety and Efficacy of BZ019 in (R/R) Large B-cell Lymphoma
NCT06224296The Exploratory Study About the Effect of Using Double Filtration Plasmapheresis (DFPP) Removing Inflammatory Cytokines, Lipids and Toxic Metal Ions in Peripheral Blood in Adults
NCT04503980αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors
NCT05472610Study of Efficacy of BZ019 in Large B-cell Lymphoma
NCT06015269Exploratory Study on Baize DC Injection in Preventing Recurrence and Metastasis After Radical Tumor Surgery
NCT05984550The Exploratory Study on the Nicotinamide Mononucleotide (Vital NAD ) to Promote the Rejuvenation of the Peripheral Blood Immune Cells of Adults.
NCT04067414Exploratory Study of CD19-targeted Chimeric Antigen Receptor T Cells(BZ019) for Relapsed and Refractory B-cell Lymphoma
NCT06036355The Exploratory Study on the Biological Function of Dendritic Cells In Vivo Supported by Nicotinamide Mononucleotide (Vital NAD)
NCT06732232A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed/ Refractory Multiple Myeloma
NCT06249256An Exploratory Study on the Treatment of Advanced Solid Tumors by Fast CAR T Cells
NCT05373147αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors
NCT05997628The Exploratory Study on the Baseline Level of NAD+/NADH in Peripheral Blood Samples of Different Gender and Age Groups of Healthy Adults.
NCT05944185Phase I/II Study of αPD1-MSLN-CAR T Cells in MSLN-positive Advanced Solid Tumors
NCT06446128A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed or Refractory B Cell Non-Hodgkin Lymphoma(NHL)
NCT06327997An Exploratory Study by Fast CAR T Cells
NCT06248697Exploratory Study of MSLN-CAR T Cells Secreting PD1/CTLA-4 Nanoantibody for the Treatment of Advanced Solid Tumors